DTSS News & Events

Datasea announced initial commercial rollout progress in the United States for its acoustic technology-enabled health and wellness care robot solutions, developed in collaboration with Yizhimei Technology. According to the Company's partners, customer signings have recently been secured and early-stage deployments have been initiated across multiple U.S. regions, including Boston, New Jersey, Los Angeles, and Phoenix, representing an early step in the Company's efforts to expand into the U.S. market. Building on its prior activities in China and other Asian markets, the Company is working with partners to explore the deployment of acoustic-technology-enabled solutions in additional healthcare and wellness settings. As previously disclosed, the Company has also been advancing initial customer deployments and market exploration in other international markets, including South Korea, Hong Kong SAR, Taiwan region, Singapore, Indonesia, and Malaysia. The Company believes these initial deployments are expected to cover multiple service locations and operational terminals, primarily within hospital-related environments, beauty service providers, and wellness centers. These developments represent an early step in Datasea's U.S. commercialization strategy and are expected to support the initial generation of service-related revenues in the U.S. market, while providing validation for the Company's scalable "technology + service + application scenario" business model. At this stage, Datasea primarily provides core acoustic technology, technical service support, and scenario-based solutions to empower partners in deploying acoustic technology-enabled wellness care robots across hospitals, beauty service settings, wellness centers, and other health service environments. Based on the Company's current cooperation structure, potential revenue streams associated with these deployments may include technical service fees, solution integration income, and recurring service-related revenues linked to deployed terminals, subject to ongoing commercialization progress.

Datasea announced continued progress in its collaboration with Yizhimei Technology Co. relating to technical services and commercial deployment of acoustic + AI head-care robots for health and wellness applications. Under the framework of the existing cooperation agreement, the company has achieved initial technical service revenue. In addition, the parties have further entered into an expanded cooperation arrangement to jointly advance the research and development of acoustic AI health care robots and accelerate market expansion. The upgraded collaboration marks a transition from an initial technology-enablement phase to a stage focused on product commercialization and broader industrial deployment.

Datasea has achieved "a foundational research breakthrough" in its ultrasonic-enhanced nanoscale precision control technology, representing a step-change in the Company's technical architecture and underlying acoustic engineering capabilities. The company said, "This milestone also marks the establishment of an engineering-level core technology architecture oriented toward next-generation semiconductor manufacturing applications. The Company stated that this breakthrough reflects progress at the foundational research and architectural levels, rather than a single-point laboratory result. By systematically integrating ultrasonic enhancement mechanisms with ultra-precision composite manufacturing processes, Datasea is constructing a systems-level precision control architecture and related technical framework designed to address increasing complexity, stability, and nanoscale accuracy requirements in advanced semiconductor process environments. This stage of R&D progress provides a technical foundation for subsequent engineering validation and application scenario exploration. The technology remains in the research and engineering validation stage and has not yet entered commercialization."

Reports 2H26 gross profit $2.36M vs.$0.61M in the same period last year, representing an increase of $1.75M, or 284.4% year-over-year. Zhixin Liu, CEO, commented, "The first half of fiscal 2026 reflects our continued execution of a strategic shift away from top-line growth toward higher-quality revenue and improved profitability. While revenue declined year-over-year as a result of our deliberate reduction of low-margin standardized services, both gross profit and gross margin expanded meaningfully, underscoring the effectiveness of our technology-driven, higher-value business mix...At the same time, we are advancing our acoustic high-tech initiatives designed to extend our technology leadership and future growth. Our R&D is increasingly centered on non-invasive acoustic medicine, brain-computer interface technologies, intelligent acoustic systems and health robotics. In parallel, we are exploring the technical capabilities and application potential of acoustic technologies in industrial and precision manufacturing environments. Collectively, these initiatives both augment and strengthen our core technology, and broaden our addressable markets, positioning the Company's for future growth beyond its current core businesses."